The role of Minimally Invasive Surgery (MIS) in the treatment of different gynecological cancers is controversial and oncological surgery is constantly evolving. On the one hand, MIS has many benefits in terms of reduced inpatient stay, improved recovery, reduced blood loss and postoperative morbidity. On the other hand, the recent Laparoscopic Approach to Cervical Cancer (LACC) trial has unexpectedly reported inferior oncological outcomes with lower survival rates for women undergoing MIS compared with open surgery, creating a heated debate on this topic. Until the publication of the LACC trial, minimally invasive radical hysterectomy was the recommended approach to treat patients with early-stage cervical cancer. The future of MIS for cervix cancer, however, remains uncertain: several retrospective studies have denied these findings, confirming the low complication rate of MIS.
MIS is the standard of care for endometrial cancer, and a valid option for ovarian cancer surgical management.
In the current scenario, is the MIS approach still a safe option? Does minimally invasive surgery still play a role in the treatment of cervical cancer? Is a personalized approach possible or are there differences according to the type of tumor, stage of disease and/or clinical characteristics of the patient? In this context it is mandatory to assess safety, oncological outcomes, and benefits of this type of surgery, considering laparoscopic and/or robotic approach. The goal of this Research Topic is to clarify and define a new path to follow on mini-invasive approach, evaluating current evidence and further prospective.
The role of Minimally Invasive Surgery (MIS) in the treatment of different gynecological cancers is controversial and oncological surgery is constantly evolving. On the one hand, MIS has many benefits in terms of reduced inpatient stay, improved recovery, reduced blood loss and postoperative morbidity. On the other hand, the recent Laparoscopic Approach to Cervical Cancer (LACC) trial has unexpectedly reported inferior oncological outcomes with lower survival rates for women undergoing MIS compared with open surgery, creating a heated debate on this topic. Until the publication of the LACC trial, minimally invasive radical hysterectomy was the recommended approach to treat patients with early-stage cervical cancer. The future of MIS for cervix cancer, however, remains uncertain: several retrospective studies have denied these findings, confirming the low complication rate of MIS.
MIS is the standard of care for endometrial cancer, and a valid option for ovarian cancer surgical management.
In the current scenario, is the MIS approach still a safe option? Does minimally invasive surgery still play a role in the treatment of cervical cancer? Is a personalized approach possible or are there differences according to the type of tumor, stage of disease and/or clinical characteristics of the patient? In this context it is mandatory to assess safety, oncological outcomes, and benefits of this type of surgery, considering laparoscopic and/or robotic approach. The goal of this Research Topic is to clarify and define a new path to follow on mini-invasive approach, evaluating current evidence and further prospective.
